Vaccination & Population Control
The “swine flu” vaccine contains ingredients that impair
fertility.
Daniel Solis from the Czech Republic
has researched the side-effects of the adjuvant, squalene, and discovered it is
known to destroy fertility as well as causing other forms of damage.
A patent for a vaccine to impair fertility in animals
contains squalene.
The plan to use this fertility-impairing adjuvant in the
“swine flu” vaccine against a flu that has so far been far less irksome than
the ordinary seasonal flu underscores concerns that this H1N1 mass vaccination
programme mandated by WHO with the support of pharma companies such as Baxter
is designed primarily to cause death and injury, and so significantly reduce
the global population.
Is it any wonder that these “vaccines” are classified as
bioweapons by the regulators?
For expert information on the dangers of vaccines, check
out Dr Rebecca Carley’s website.
http://www.drcarley.com/
Daniel Solis has also made a formal complaint against the
head of the Czech Republic’s FDA and the Deputy Health Minister for awarding a
contract to Baxter worth 1,5 billion CZK without an open tender. More legal
action in the Czech Republic is planned with the aim of getting Baxter’s
licence to manufacture the “swine flu” vaccine at Bohumil suspended and to make
Baxter accountable for the incident at the BioTest lab, which detected the live
bird flu virus in vaccine material from Baxter on February 6th. Members of the
lab had to be treated preventatively for bird flu and were put in quarantine.
Also, a Czech translation of “Evidence-of-the-Use-of-Pandemic-Flu-to-Depopulate-USA”
can be found here:
http://www.outsidermedia.cz/Obvinuji-Vas-z-masove-vrazdy-1.aspx
http://www.outsidermedia.cz/Obvinuji-Vas-z-pripravy-masove-vrazdy-II-1.aspx
“I have focused on the adjuvants made of monophosforyl
lipid A (MPL) MF59TM (containing a polysorpate TweenTM 80) or AS03, AS04 also
known as squalene in the proposed vaccines, which are immunosterilant or an
immunocontraceptive,” Daniel Solis writes.
“The patent of the veterinary FERTILITY IMPAIRING VACCINE
can be found on-line. It mentions both, the lipoid adjuvans squalene and the
polysorbate TM80.
Here are the qotes from the patent and further some
clinical studies about the toxicity of both.
(WO/1999/034825) FERTILITY IMPAIRING VACCINE AND METHOD OF
USE
This application claims the benefit of U. S. Provisional
Application No. 60/070,375, filed January 2,1998, U. S. Provisional Application
No. 60/071,406, filed January 15,1998
“The vaccine of the invention preferably additionally
includes an immunological adjuvant to enhance the immunological response of the
subject to the glycoprotein antigen. Examples of adjuvants include Freund’s
Complete Adjuvant, Freund’s Incomplete Adjuvant, and an adjuvant comprising an
immunostimulant such as synthetic trehalose dicorynomycolate (STDCM) and an oil
such as squalene oil (see P. Willis et al., J. Equine Vet. Sci., 14,364-370
(1994)). An adjuvant comprising synthetic trehalose dicorynemycolate, squalene
oil, and a surfactant such as lecithin is preferred. Lecithin typically
includes phosphatidyl choline. In a preferred embodiment the vaccine comprises
oil, preferably a biodegradable oil such as squalene oil. Typically, the
vaccine is prepared using an adjuvant concentrate which contains lecithin in
squalene oil. The aqueous solution glycoprotein is typically a
phosphate-buffered saline (PBS) solution, and additionally preferably contains
Tween 80.”
Abstract:
A vaccine comprising an antigen derived from a zona
pellucida glycoprotein is effective to impair fertility in animals, preferably
carnivores. The vaccine can be used as an immunosterilant or an
immunocontraceptive.
http://www.wipo.int/pctdb/en/wo.jsp?wo=1999034825
Description:
http://www.wipo.int/pctdb/en/wo.jsp?IA=US1998027658&wo=1999034825&DISPLAY=DESC
__________________________________________________________
Annals of Allergy, Asthma and Immunology, Volume 95,
Number 6, December 2005 , pp. 593-599(7)
“Polysorbate 80 was identified as the causative agent for
the anaphylactoid reaction of nonimmunologic origin in the patient.
Conclusions: Polysorbate 80 is a ubiquitously used solubilizing agent that can
cause severe nonimmunologic anaphylactoid reactions.”
Gajdova M, Jakubovsky J, Valky J.
Institute of Preventive and Clinical Medicine, Limbová,
Bratislava.
Delayed effects of neonatal exposure to Tween 80 on female
reproductive organs in rats. Food Chem Toxicol. 1993 Mar;31(3):183-90. PMID:
8473002.
“Baby female rats were injected with polysorbate 80 at
days 4-7 after birth. It accelerated the maturing of the rats and caused
changes to the vagina and womb lining, hormonal changes, ovary deformities and
degenerative follicles.”
http://www.ncbi.nlm.nih.gov/pubmed/8473002
The Endogenous Adjuvant Squalene Can Induce a Chronic
T-Cell-Mediated Arthritis in Rats
Barbro C. Carlson*, Åsa M. Jansson*, Anders Larsson,
Anders Bucht and Johnny C. Lorentzen*
http://ajp.amjpathol.org/cgi/content/abstract/156/6/2057
__________________________________________________________
Now, how can WHO claim the adjuvans is harmless:
http://www.who.int/vaccine_safety/topics/adjuvants/squalene/questions_and_answers/en/index.html
when there is clear evidence of its effects provoking AI
deseases:
ANTI-SQUALENE ANTIBODIES LINK GULF WAR SYNDROME TO ANTHRAX
VACCINE
http://www.autoimmune.com/GWSGen.html
or
“Dr. Jules Freund creator of this oil-based adjuvant
warned in 1956 that animals injected with his formulation developed terrible,
incurable conditions: allergic aspermatogenesis (stoppage of sperm production),
experimental allergic encephalomyelitis (the animal version of MS), allergic
neuritis (inflammation of the nerves that can lead to paralysis) and other
severe autoimmune disorders.
Source: : Gary Matsumoto, Vaccine A-The Covert Government
Experiment That’s Killing our Soldiers and Why GI’s are Only the First Victims,
Kapitola 3. “The Greatest Story Never Told”
http://www.vaccine-a.com/excerpt.html”
Daniel Solis, Prague, Czech Republic
http://www.denikpolitika.cz/politici/daniel-solis/blog#31
http://www.czechfp.cz/site/?p=8009
Baillieres Clin Obstet Gynaecol. 1996
Apr;10(1):69-86.
Contraceptive vaccines.
Jones WR1.
Abstract
The basic principle of a contraceptive
(or anti-fertility) vaccine is to use the body's own immune defence mechanisms
to provide protection against an unplanned pregnancy. Factors such as: economic
production, convenience of use, relatively long-lasting but reversible action,
low failure rate, and the avoidance of mechanical devices or exogenous hormones
make this approach a potentially attractive option for family planning
programmes in both developing and developed countries. The major efforts in
research and development have involved the prospect of active immunization
against specific antigens of sperm, ovum, zygote and early embryo, and the
pregnancy hormone hCG. Several anti-hCG vaccines have entered clinical trials
and show promising results. These vaccines operate by preventing or
interrupting pregnancy at the peri-implantation stage probably by neutralizing
the luteotrophic action of hCG. The most refined vaccine is one directed
against the unique C-terminal peptide on the beta-subunit of hCG. This vaccine
provokes antibodies that are specific for hCG and do not cross react with hLH.
Future research efforts aim to optimize the anti hCG approach, utilize new
vaccine delivery systems, and broaden the spectrum of target antigens of
potential utility for contraceptive vaccines.
Contraceptive vaccine for Deer
Population
https://blog.humanesociety.org/2017/07/epa-gives-thumbs-vaccine-manage-deer-populations-humanely.html
Similar
to the Zonastat-H vaccine, whose use in the
humane control of wild horse populations is well established and effective,
Zonastat-D is the trade name for the porcine zona pellucida (PZP) vaccine,
adapted for deer. PZP blocks fertilization by triggering the production of
antibodies that bind to the protein envelope surrounding the egg.
Adding this vaccine
to the management toolbox enables wildlife managers to reduce populations
gradually, often without resorting to lethal methods. Sport hunting or
sharpshooting management options are often considered unsafe, impractical, and
unpalatable in many urban and suburban communities.
The HSUS has
traveled a long road with its partners to reach this point. Field studies on
deer that provided the foundation for this registration stretch back to 1993,
when scientists from the Science and Conservation Center in Billings, Montana,
and the University of Toledo joined HSUS staffers to administer the first
PZP-filled darts to deer at Fire Island National Seashore in New York.
Subsequent HSUS field studies at the National Institute of Standards and
Technology – our neighbors in Gaithersburg, Maryland – and a collaboration with
Tufts University at Fripp Island, South Carolina, provided more validation.
These were experimental programs, and the authorization for the use of the vaccine
had only been made at these select locations.
Having treated many hundreds of deer with PZP, HSUS
scientists and other researchers who have experience with the vaccine have
abundant evidence to demonstrate that it’s safe for the animals, doesn’t pass
through the food chain, and is effective in reducing reproductive success. When
used properly, PZP reduces fawning rates by 85 to 90 percent. The EPA’s
approval of the vaccine affirms those conclusions, and I’m pleased to see this
piece of good news for animals coming out of the Trump administration.
Vaccines for feline contraception: GonaCon GnRH-hemocyanin
conjugate immunocontraceptive.
Review article
Benka VA, et al. J Feline Med Surg. 2015.
https://www.ncbi.nlm.nih.gov/m/pubmed/26323799/
Abstract
VACCINE: GonaCon™ is the trade name of a GnRH-hemocyanin conjugate
immunocontraceptive vaccine formulation shown to prevent reproduction and
inhibit production of sex hormones in numerous mammalian species for extended
durations. GonaCon is currently registered with the US Environmental Protection
Agency (EPA) for contraception of female white-tailed deer, and GonaCon™-Equine
for female wild horses and burros. Multiple formulations of this
GnRH-hemocyanin conjugate immunocontraceptive vaccine have been developed at
the National Wildlife Research Center in the United States.
GonaCon™—Birth
Control for Deer: Questions and Answers
Q. What is GonaCon™?
A. GonaCon™ is a new gonadotropin-releasing
hormone (GnRH) immunocontraceptive vaccine developed by scientists at the U.S.
Department of Agriculture’s (USDA) Wildlife Services’ (WS) National Wildlife
Research Center (NWRC). Presently, applications of GnRH are being researched in
controlled field studies
Immunocastration of goats using anti-gonadotrophin releasing
hormone vaccine.
Lents MP, et al. Theriogenology. 2018.
https://www.ncbi.nlm.nih.gov/m/pubmed/29574307/
Abstract
The aim of this study was to evaluate the immuno-sterilizing
action of anti-gonadotrophin-releasing hormone (anti-GnRH) vaccine in goats.
Fertility control of “pest mammals”
Environmental degradation
and economic losses due to pest populations of native and exotic mammals are
widespread problems1,2 and
immunocontraception has been heralded as a potential solution to these problems.3, 4, 5 Immunocontraceptive
vaccines are designed to target the reproductive system of pest mammals by
promoting antibody production against various proteins necessary for
reproduction.6 The potential
end result is a publicly acceptable and humane control over wildlife numbers.
Nevertheless, the application of this method to wildlife populations is still
in its infancy and several concerns have been raised regarding detrimental
consequences of immunocontraception.7 One of the
most controversial issues involves selection for individuals who fail to mount
a significant contraceptive response to the immunogen and hence remain fertile
in the presence of the vaccine. It is possible that the progeny of these
individuals will inherit this resistance in which case alleles of genes
responsible will increase in frequency. Thereby biocontrol via
immunocontraception will become increasingly ineffective over time due to
strong selective pressures in favour of non-response to the immunocontraceptive.8
Post a Comment